Tennis champion Novak Djokovic has an 80% stake of Danish biotech company QuantBioRes, which is aiming to expand a scientific remedy to counter COVID-19, the corporate’s leader govt instructed Reuters on Wednesday.
CEO Ivan Loncarevic, who described himself as an entrepreneur, stated the funding was once made in June 2020 however declined to mention how a lot it was once.
QuantBioRes has round 11 researchers running in Denmark, Australia and Slovenia, in step with Loncarevic, who wired they had been running on a remedy, now not a vaccine.
The corporate is growing a peptide, which inhibits the coronavirus from infecting the human cellular, expects to release scientific trials in Britain this summer season, he added.
A spokesperson for Djokovic didn’t straight away reply to a request for remark.
The tennis primary has stoked world debate concerning the rights of people that decide to not get vaccinated after he was once deported from Australia on Sunday night time, ruling him out of the Australian Open.
